Discussions on Diversity: Gender Identity
Among clinical research’s underrepresented groups: transgender and nonbinary people. One study estimates there are 1.6 million transgender people in the U.S. alone and about one-quarter of those people identify as nonbinary1. In the latest U.K. census, 262,000 respondents identified as transgender, including 30,000 nonbinary respondents2. In clinical trials, these communities have been nearly unaccounted for.
Guided by the dual goals of greater understanding and wider inclusion, Parexel set out to investigate the key barriers to gender diversity in clinical research.
Related Insights
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Preparing for the New Era of Hybrid Regulatory Inspections
Jul 11, 2022
Video
Ensuring Diversity & Inclusion for Clinical Trials
Jul 8, 2022
Article
Xenotransplantation: Market Disrupter or Expander?
Jul 6, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology
Jun 24, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Article
ASCO 2022: Striving to Ensure No Patient is Left Behind
Jun 16, 2022
Podcast
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Jun 16, 2022
Blog
Mitigating FSP talent shortfalls through development
Jun 14, 2022
Blog
Adapting drug supply strategies to modern study models
Jun 1, 2022
Related Insights
Report
New Medicines, Novel Insights: Accelerating the new frontiers in neuroscience
Oct 29, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Preparing for the New Era of Hybrid Regulatory Inspections
Jul 11, 2022
Video
Ensuring Diversity & Inclusion for Clinical Trials
Jul 8, 2022
Article
Xenotransplantation: Market Disrupter or Expander?
Jul 6, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology
Jun 24, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Article
ASCO 2022: Striving to Ensure No Patient is Left Behind
Jun 16, 2022
Podcast
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Jun 16, 2022
Blog
Mitigating FSP talent shortfalls through development
Jun 14, 2022
Blog
Adapting drug supply strategies to modern study models
Jun 1, 2022